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a  b  s  t  r  a  c  t
Metabolic  syndrome  (MetS)  is  a cluster  of  cardiovascular  and  metabolic  abnormalities  that  together  may
increase the  risk  of  developing  cognitive  decline  and  dementia;  however,  the  neural  substrate  is  incom-
pletely  understood.  We  investigated  cortical  thickness  in  the  medial  temporal  lobe  (MTL),  hippocampal
volume,  as  well  as relationships  among  metabolic  risk  factor  burden,  structure  and  memory  perfor-
mance.  Path-analytic  models  were  tested  to explore  the relations  between  MetS  risk  factor,  structure
and  memory  performance.  Participants  were  65 non-demented,  middle-aged  and  older  adults,  34 with
and 31  without  metabolic  syndrome.  We  analyzed  archival  T1-weighted  magnetic  resonance  imaging
(MRI)  acquired  at 3T and  Total  Recall  and Delayed  Recall  scores  from  the  Brief Visuospatial  Memory  Test
Revised  (BVMT-R).  Middle-aged  adults  with  MetS  showed  less  MTL  thickness,  particularly  in entorhinal
cortex;  while  older  adults  showed  a  trend  for left  hippocampal  volume  loss.  Lower  MTL  thickness,  par-
ticularly  in  entorhinal  cortex,  was  associated  with  greater  metabolic  risk  factor  burden  in  middle-aged
adults.  In older  adults,  hippocampal  volume  was  associated  with  Total  Recall  and  Delayed  Recall,  while
in  middle-age  entorhinal  cortical  thickness  mediated  the  association  between  metabolic  disease  burden
and episodic  memory  function.  The  differential  ﬁndings  in  middle-aged  and  older  adults  with  MetS  con-
tribute  to an  understanding  of  the relationships  between  metabolic  syndrome,  structural  changes  in  the
or co
rs.  Pubrain  and  increased  risk f
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1. Introduction
The metabolic syndrome (MetS) is characterized by a cluster
of inter-related and commonly co-occurring metabolic and cardio-
vascular risk factors. Individuals with MetS are twice as likely to
develop cardiovascular disease over the next 5–10 years as individ-
uals without MetS. In addition, those with MetS are at ﬁve times
greater risk for type 2 diabetes mellitus (T2DM). The rising preva-
lence of MetS has rendered MetS both a clinical problem and a
public health issue [1].
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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There is increasing evidence that metabolic markers increase
he risk for cognitive decline and late life dementia. There are
eports that MetS negatively affects memory, visuospatial abili-
ies, executive functioning, processing speed, and general cognitive
unctioning [2]. MetS in both middle-aged and older adults has also
een reported to be associated with risk for dementia, including
lzheimer’s disease (AD) and vascular dementia [3,4]. Studies of
etabolic syndrome in midlife suggest that individual components
f MetS may  increase the risk for dementia in an additive fashion
3,5]. Taken together, research on MetS and the cumulative effect
f MetS components has increasingly reported that the presence
f MetS as early as midlife can increase risk for future dementia,
uggesting the important inﬂuence that metabolic syndrome has
n susceptibility to neurodegenerative disease.
In investigations of MetS and structural brain changes, previous
esearch demonstrated microstructural changes associated with
etS [6]. In line with neuropsychological reports of impaired per-
ormance on tasks that rely on frontal lobe function, Kaur et al.
emonstrated that thinner cortical mantle in the inferior frontal ROI
as associated with number of MetS risk factors [7]. Thus, there is
vidence that MetS is associated with structural brain changes and
hat these changes are related to number of MetS risk factors.
Given the increasing evidence for an elevated risk for cognitive
mpairment in MetS and the wealth of evidence that AD-associated
eurodegeneration begins in the medial temporal lobe (MTL),
here have been surprisingly few investigations of the relationship
etween performance on memory measures and the integrity of
TL  areas in individuals with metabolic syndrome. AD-associated
eurodegeneration begins in the entorhinal/transentorhinal area
nd then progresses to other MTL  structures, including the hip-
ocampus [8]. Since MetS is associated with increased risk for
D, an investigation of how MetS related to MTL structures, and
peciﬁcally entorhinal cortex and hippocampus, is particularly
mportant. Song et al. examined cortical and subcortical thickness
nd volumes and reported reduced thickness in entorhinal cor-
ex, but not other MTL  regions. Potential relationships between
tructural compromise and memory performance were not inves-
igated [9]. In healthy adults, it has been shown that entorhinal and
ippocampal shrinkage predicts episodic memory performance
10,11]. Thus, there is evidence of relationships between MetS
nd reduced entorhinal thickness, and between MTL changes and
pisodic memory performance in healthy adults, but past research
as not adequately explored whether MTL  structure mediates the
elationship between MetS and episodic memory performance.
The purpose of the present study was to investigate struc-
ural differences in cortical thickness in brain regions known to
e targeted early by neurodegenerative processes, i.e., the MTL, and
peciﬁcally the entorhinal cortex and hippocampus, in middle-aged
nd older adults with MetS and the relationships among structure,
etS risk factors burden and memory performance. We  made the
ollowing four hypotheses: (1) Due to the relationship between
etS and AD and evidence of structural brain abnormalities asso-
iated with MetS, it was hypothesized adults with MetS would
ave smaller estimates of cortical thickness in MTL  structures and
maller volumes of the hippocampus relative to controls [3,4,9];
2) Given previous ﬁndings showing relationship between cortical
hickness and number of MetS risk factors, it was hypothesized cor-
ical thickness in MTL  and the entorhinal cortex, and hippocampal
olume would be associated with the number of MetS risk factors
7]; (3) It was hypothesized cortical thickness in MTL  structures and
ippocampal volume would be associated with memory perfor-
ance as these structures are critical to memory function [8]; and4) Given previous evidence showing that MetS is associated with
educed entorhinal cortex [9] and other structural abnormalities
6], and evidence demonstrating relationships between MTL  and
emory decline, it was hypothesized that the relationship betweenLetters 636 (2017) 225–232
MetS and memory performance would be mediated by structural
changes in the MTL.
2. Materials and methods
2.1. Participants
Demographic data for the 65 participants (36 F, 29 M)  are
shown in Table 1. There were three study visits. Participants per-
formed screening and clinical measures in the ﬁrst, functional MRI
(fMRI) neuroimaging in the second and cognitive testing in the
third. Participants were screened for the following exclusionary
criteria: left-handedness, neurological disorders, substance abuse,
history of traumatic brain injury with at least ﬁve minutes loss
of consciousness, and contraindications for MRI. Additionally, par-
ticipants completed the Mini-Mental State Examination (MMSE)
and adults > 60 completed the Dementia Rating Scale-2 (DRS-2)
to screen for dementia. No older adults were excluded based on
MMSE  or DRS-2 scores. MetS status was  determined using the
International Diabetes Federation guidelines for clinical diagnosis
of MetS [1]. Thus, MetS participants (n = 34) had at least three of
the following: elevated waist circumference, elevated triglycerides,
decreased high density lipoprotein (HDL) cholesterol levels (or
treatment for HDL cholesterol), elevated systolic and/or diastolic
blood pressure (or antihypertensive drug treatment), and elevated
fasting glucose or T2DM diagnosis. Participants who  did not meet
the clinical criteria for MetS comprised the healthy control group
(n = 31). Participants gave informed consent and were compen-
sated after each study visit. The study was conducted according
to the principles of the Declaration of Helsinki and approved by the
Institutional Review Boards at San Diego State University and the
University of California, San Diego.
2.2. Clinical data
Clinical data acquired during the screening session included
height, weight, waist circumference, and blood pressure. Height
and weight were determined using a stadiometer and digital scale.
Body mass index (BMI) was  calculated by dividing the participant’s
weight (kilograms) by height (meters) squared. Waist circumfer-
ence (centimeters) was measured at the midpoint between the top
of the hip bone (iliac crest) and the lowest point of the ribcage.
Blood pressure was computed using the average of three seated
measurements using an electronic blood pressure monitor. Partic-
ipants completed a questionnaire to establish current medications
being used to treat hypertension, dyslipidemia, or T2DM.
2.3. MRI
We  analyzed archival high-resolution T1-weighted scans that
had all been acquired on the same 3T GE Discovery MR750 scanner.
2.3.1. Scan parameters
Thirty-nine participants were scanned using a high-resolution
T1-weighted fast spoiled gradient (FSPGR) echo sequence with the
following parameters: ﬁeld of view (FOV) = 25.6 cm,  slice thick-
ness = 1.2 mm,  resolution 1 × 1 × 1 mm3, echo time (TE) = 30 ms,
Locs per slab = 190, ﬂip angle = 15◦. The data for the remaining
twenty-six participants were collected using a T1-weighted inver-
sion recovery spoiled gradient (IR-SPGR) echo sequence with the
following parameters: ﬁeld of view (FOV) = 24 cm,  slice thick-
ness = 1.2 mm,  resolution 0.9375 × 0.9375 × 1.2 mm3, echo time
(TE) = 3 ms,  Locs per slab = 170, ﬂip angle = 8◦. The T1-weighted IR-
SPGR sequence was collected using an image-based prospective
motion correction technique (PROMO) in real time. Because fMRI
upgraded the software for the T1 scans during the time periods of
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Table  1
Demographic and clinical data of MetS and control groups.
Mid-Age Participants (N = 34) Control (N = 16) MetS (N = 18) t (2) P
Mean (SD)
Age 49 (0.82) 50.72 (1.01) −1.30 0.203
Education 15.13 (0.66) 14.61 (0.58) 0.59 0.56
Gender (% Male) 43.8 27.8 (0.95) 0.331
MMSE  29.31 (0.22) 29 (0.41) 0.65 0.523
BMI  25.22 (0.62) 40.29 (1.35) −9.75 <0.001
Waist  Circumference 91.69 (3.11) 126.27 (4.82) −5.86 <0.001
Systolic BP 122.22 (4.45) 142.13 (2.96) −3.80 0.001
Diastolic BP 75.52 (2.72) 85.6 (1.84) −3.13 0.004
Risk  Factor Burden 0.88 (0.18) 3.11 (0.18) −8.79 <0.001
BVMT-R Total Recall 24.60 (4.39) 21.23 (8.37) – –
BVMT-R Delayed Recall 10.20 (1.42) 8.62 (3.28) – –
Older  Participants (N = 31) Control (N = 15) MetS (N = 16) t (2) P
Mean (SD)
Age 70.4 (1.56) 68.25 (1.81) 0.90 0.378
Education 14.67 (0.67) 14.72 (0.62) −0.06 0.955
Gender (% Male) 60.0 50.0 (0.31) 0.576
MMSE  28.53 (0.44) 28.69 (0.34) −0.28 0.78
BMI  24.79 (0.72) 31.48 (1.09) −5.05 <0.001
Waist  Circumference 88.95 (2.08) 112.01 (2.86) −6.45 <0.001
Systolic BP 139.51 (4.97) 138.63 (4.75) 0.13 0.9
Diastolic BP 72.01 (2.1) 77.17 (2.43) −1.60 0.121
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BVMT-R Delayed Recall 8.67 (2.72) 
his study, scan parameters were different between participants.
o control for this, type of scan was used as a covariate in analyses.
.3.2. Image processing
T1-weighted structural scans were processed using the
reeSurfer image analysis suite, version 5.2.0 (http://surfer.nmr.
gh.harvard.edu). Standard FreeSurfer automated processing pro-
edures were employed [12,13]. Each subject’s post-processing
utputs were manually inspected for reconstruction accuracy in
he Talairach transform, skull strip, white and pial surfaces, and
egmentations. Cortical thickness regions of interest and volumet-
ic estimates were extracted from automatic surface parcellation
abels using the Desikan/Killiany Atlas [14]
.4. Cognitive data
The Brief Visuospatial Memory Test-Revised (BVMT-R) [15], an
pisodic memory test that assesses learning and memory, was
dministered. We  examined BVMT-R Total Recall (total score of
hree recall trials) and Delayed Recall because these have been
eported to be effective in discriminating between middle-aged
dults that remain stable or show cognitive decline and decline
n episodic memory is an early cognitive change that precedes AD
16].
.5. Statistical analysis
All statistical analyses, except for mediation analyses (Mplus),
ere performed using Statistical Package for the Social Sciences
SPSS, version 21). Nine participants did not undergo the cogni-
ive testing, thus, analyses involving cognitive testing included 28
iddle-aged (13 MetS) and 28 older adults (13 MetS). To preserve
ower, analyses not involving the cognitive data were performed
n the full cohort: 34 middle-aged (18 MetS) and 31 older adults
16 MetS).3.19 (0.14) −12.17 <0.001
20.00 (7.88) – –
8.23 (3.03) – –
2.5.1. Demographics and clinical data
For both the middle-aged and older adult groups (N = 34, N = 31,
respectively), two-tailed independent sample t-tests were con-
ducted on age, education, MMSE, BMI, waist circumference, and
systolic and diastolic blood pressure, and risk factor burden to
examine group differences in demographics and clinical data. Addi-
tionally, chi-square analyses were used to examine differences in
gender. Group differences in memory measures (BVMT-R Total
Recall and Delayed Recall) were assessed in middle-aged and older
adults using ANCOVA, controlling for age, education, and gender.
Bonferroni-Holm correction was applied.
2.5.2. Group MRI analysis
To test our ﬁrst hypothesis, Analysis of Covariance (ANCOVA)
was performed to examine group differences (MetS vs. control) in
global brain measures, cortical thickness of the MTL, the entorhinal
cortex, and hippocampal volumes, in middle-aged and older adults
separately. Estimates of cortical thickness of structures in the MTL
and hippocampal volumes were extracted from automatic surface
parcellation labels using the Desikan/Killiany Atlas. For each hemi-
sphere, cortical thickness estimates of the MTL  were calculated
by computing the average thickness of MTL structures (entorhi-
nal cortex, parahippocampal gyrus, temporal pole, fusiform gyrus).
In addition, because of their importance in the early develop-
ment of neuropathology in AD, we investigated entorhinal cortex
thickness and hippocampal volume. Cortical thickness in bilateral
areas (MTL) and hippocampal volumes were assessed for laterality
effects using paired t-tests. Since there were signiﬁcant differ-
ences in MTL  thickness and hippocampal volume between the
left and right hemispheres (p < 0.01), each hemisphere was exam-
ined separately in subsequent analyses. In all analyses, age, type
of T1 scan, and gender were included as covariates. Additionally,
estimated intracranial volume was controlled for in volumetric
analyses. Groups were assessed for differences in nine structural
measures: total MTL  thickness, left/right MTL  thickness, and indi-
vidual MTL  memory regions (total/left/right entorhinal cortical
thickness, total/left/right hippocampal volume). Effect sizes (partial
eta-squared, p2) were calculated for all between-group compar-
2 ience Letters 636 (2017) 225–232
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Table 2
Effect of MetS on MTL  structures.
Region of Interest Effect of MetS
Mid-Age Participants (N = 34) F p p2
MTL  Thickness 9.28 0.005 0.242
L  MTL  Thickness 8.42 0.007 0.225
Entorhinal Thickness 5.87 0.022 0.168
L  Entorhinal Thickness 8.56 0.007 0.228
R  MTL  Thickness 7.14 0.012 0.198
Older Participants (N = 31)
NS
Table 3
Correlations between risk factor burden and structural measures of medial temporal
lobe.
Region of Interest Corr. w/Risk Factor Burden
Mid-Age Participants (N = 34) R p
MTL  Thickness −0.55 0.001
L  MTL  Thickness −0.49 0.005
Entorhinal Cortex Thickness −0.46 0.010
L  Entorhinal Cortex Thickness −0.43 0.017
R  MTL  Thickness −0.53 0.00228 E.C. McIntosh et al. / Neurosc
sons. To correct for multiple comparisons, the Bonferonni-Holm
orrection was applied for each hemisphere separately. Unless oth-
rwise speciﬁed, all MRI  comparisons examined the same nine
alues described above.
.5.3. Structural and clinical data relationships
To address the second hypothesis, two-tailed partial bivari-
te Pearson correlations between cortical thickness and volume
stimates and metabolic risk factor burden were performed in
iddle-aged and older adults. Metabolic risk factor burden was
etermined by summing the total number of MetS criteria a par-
icipant met  (range from) 0–4. We  combined criteria for low HDL
holesterol and high triglyceride levels into one criterion (referred
o as dyslipidemia). To assess the speciﬁcity of our ﬁndings, these
elationships were also conducted for a control region in the occip-
tal lobe (pericalcarine cortex) that is not known to be signiﬁcantly
ffected by metabolic and cardiovascular factors or dementia. Age,
ype of T1 scan, and gender were controlled for in all partial corre-
ation analyses. Bonferroni-Holm correction was applied.
.5.4. Structural and memory performance relationships
To test the third hypothesis, the relationship between corti-
al thickness in the medial temporal region and entorhinal cortex,
ippocampal volume, and performance on memory measures
BVMT-R Total Recall and Delayed Recall) was investigated using
wo-tailed Pearson correlations, controlling for age, years of educa-
ion, and T1 type, and gender in both middle-aged and older adult
roups. The Bonferroni-Holm correction was applied.
.5.5. Metabolic risk and cognitive data: mediation analysis
To investigate the fourth hypothesis, path-analytic models
pecifying indirect relations from MetS risk factor to BVMT-R
cores (Total Recall and Delayed Recall) via entorhinal cortex in
iddle-aged adults. Since entorhinal atrophy is known to precede
ippocampal atrophy in neurodegenerative diseases like AD and
etS risk factors in mid-life are strong predictors of dementia, it
as hypothesized a priori that entorhinal cortical thickness would
ediate the relationship between MetS and memory in middle-
ged adults.
.5.6. Exploratory analyses
.5.6.1. Relationships between hypertension and brain structure.
ast research has shown hypertension, especially in middle age, to
e associated with cognitive decline and structural brain changes
3]. Therefore, relationships between blood pressure (systolic and
iastolic measurements) and cortical thickness in MTL  areas and
ippocampal volume were explored using regression analyses,
ovarying for age, gender, and T1 type. If signiﬁcant relationships
ere found, the relevant blood pressure measurement was to be
dded as a covariate to the ANCOVA model to assess the contribu-
ion of blood pressure to group differences in brain structure.
.5.6.2. Relationships between medication and brain structure. Due
o the fact that MetS was deﬁned by overt symptoms and/or use
f symptom-reducing treatments, it is unclear whether medica-
ion use could account for the differences in brain structure seen in
lder adults with and without MetS. Therefore, the effect of medi-
ation treatment on cortical thickness differences was explored in
wo additional models in middle-aged and older adults. First, use
f any medication for treatment of T2DM, hypertension, or dyslipi-
emia was coded and included as a variable of interest in ANCOVA
odels investigating structural group differences. Additionally, the
ffect of extensive medication use was evaluated by covering for
he number of medication treatments (for T2DM, hypertension,
yslipidemia) for each participant.Older Participants (N = 31)
NS
3. Results
3.1. Demographics and clinical data
There were no signiﬁcant differences between the MetS and
control groups in age, years of education, or MMSE. As expected,
there were signiﬁcant group differences in BMI, waist circumfer-
ence, metabolic risk factor burden, systolic and diastolic blood
pressure readings in middle-aged adults. In older adults, there
were signiﬁcant group differences in BMI, waist circumference,
metabolic risk factor burden, but not in blood pressure (Table 1).
ANCOVA with age, education, and gender as covariates, detected no
statistically signiﬁcant differences between the MetS and control
groups on the memory measures.
3.2. MRI  analyses
3.2.1. Analyses of brain structure
ANCOVA analyses revealed important differences in cortical
thickness between the MetS and control groups in medial tempo-
ral regions (Table 2). In middle-aged adults, relative to the control
group, the MetS group had signiﬁcantly smaller estimates of cor-
tical thickness in bilateral MTL, including the entorhinal cortex.
Additionally, middle-aged adults with MetS had signiﬁcantly lower
estimates of mean thickness in the left and right hemispheres. In
older adults, there were no signiﬁcant differences in cortical thick-
ness in any medial temporal regions. However, older adults with
MetS showed a trend toward smaller left hippocampal volumes
compared to healthy older adults that did not reach signiﬁcance
after adjusting for multiple comparisons (p = 0.046). There were no
group differences in any global volumetric or thickness measures
in the older adults. Finally, there were no differences between MetS
and control groups in the control region, the pericalcarine cortex
(p > 0.05).
3.2.2. Relationships between metabolic risk factor burden and
brain structure
Metabolic risk factor burden was negatively associated with
cortical thickness in MTL  and entorhinal cortex in middle-aged
subjects (Table 3). Figs. 1 A-2 illustrate relationships between
E.C. McIntosh et al. / Neuroscience Letters 636 (2017) 225–232 229
Fig. 1. Scatterplots depicting partial correlations between residualized values of left medial temporal cortical thickness and metabolic risk factor score and memory perfor-
mance  in middle-aged adults; A) Relationship between left medial temporal cortical thickness and number of MetS risk factors (metabolic score) controlling for age, gender,
and  T1 type, r = −0.49, p = 0.005; B) Three dimensional representation of the left medial temporal lobe; C) Scatterplot showing data for left medial temporal cortical thickness
and  performance on BVMT-R Total Recall, controlling for age, gender, and T1 type, r = 0.44, p = 0.32.
Fig. 2. Scatterplots depicting partial correlations between residualized values of left entorhinal cortical thickness and metabolic risk factor score and memory performance
in  middle-aged adults; A) Relationship between left entorhinal cortical thickness and number of MetS risk factors (metabolic score), controlling for age, gender, and T1 type,
r  = −0.43, p = 0.017; B) Three dimensional representation of the left entorhinal cortex; C) Scatterplot showing data for left entorhinal thickness and performance on BVMT-R
Total  Recall, controlling for age, gender, and T1 type, r = 0.42, p = 0.042.
Fig. 3. Scatterplots depicting partial correlations between residualized values of hippocampal volume and metabolic risk factor score and memory performance in older
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hdults; A) Relationship between hippocampal volume and number of MetS risk fac
imensional representation of the hippocampus; C) Relationship between hippoca
1  type, r = 0.40, p = 0.050.
etabolic risk factor burden and cortical thickness in left MTL
nd in the left entorhinal cortex in middle-aged subjects. Corre-
ations between number of risk factors and structural measures
ere not signiﬁcant in older adults. Fig. 3A illustrates the correla-
ion between risk factor burden and hippocampal volume in older
dults, p = 0.34. Analyses in the pericalcarine cortex (occipital con-
rol region) demonstrated no relationships between measures of
etabolic risk factor burden and cortical thickness of this region
p > 0.05). Figs. 1 B–3 B illustrate the MTL, entorhinal cortex and
ippocampus in 3D.etabolic score), controlling for age, gender, and T1 type, r = 0.19, p = 0.34; B) Three
volume and performance on BVMT-R Total Recall, controlling for age, gender, and
3.2.3. Relationships between brain structure and memory
performance
Correlations were performed between cortical thickness of MTL
and entorhinal cortex and hippocampal volume and scores on
the BVMT-R (Total Recall, Delayed Recall) (Table 4). In the older
adults, total and left hippocampal volume was  positively corre-
lated with BVMT-R Total Recall and Delayed Recall. In middle-aged
adults, relationships between left MTL  and entorhinal thickness and
BVMT-R Total Recall approached but did not reach signiﬁcance after
adjusting for multiple comparisons (p = 0.032, p = 0.042). Figs. 1 C-3
C illustrate the data in middle-aged and older adults.
230 E.C. McIntosh et al. / Neuroscience 
Table 4
Correlations between structural measures of MTL/Memory areas and BVMT scores.
Mid-Age-Participants
NS
Older Participants
Region of Interest Measure R p
L Hippocampus Volume BVMT-R Total Recall 0.51 0.013
BVMT Delayed Recall 0.56 0.005
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eHippocampus Total Volume BVMT-R Total Recall 0.49 0.019
BVMT Delayed Recall 0.54 0.007
.2.4. Relationships between metabolic risk factor burden and
emory measures: mediation analysis
As described above, previous literature has described relation-
hips between number of MetS symptoms and brain structure, and
etS and worse cognition function, including memory, but few if
ny studies have tested whether the relationship between MetS
nd cognitive function is mediated by structural brain changes. We
ocused the analysis on the left entorhinal cortex because of the
tructural ﬁndings in the present study and because of its vulnera-
ility to the very early degenerative changes in Alzheimer’s disease.
hus, we examined the hypotheses that the relationship of MetS
isk factor burden and memory performance is mediated by the
ortical thickness of left entorhinal cortex in middle-aged. Path-
nalytic models specifying indirect relations from MetS risk factor
o BVMT-R scores (Total Recall and Delayed Recall, separately) via
ntorhinal cortex were tested to explore the relationships between
etS, structure and memory in middle age.
The ﬁrst target model speciﬁed indirect relations from MetS
isk factor to BVMT-R Total Recall score via left entorhinal cortex
hickness as a mediating variable in middle-aged adults. The tar-
et model ﬁt well statistically, 2(1, N = 34) = 0.044, p = 0.833, and
escriptively Comparative Fit Index (CFI) of 1.000 and Root Mean
quare Error of Approximation (RMSEA) < 0.001. Both the effects
rom MetS risk factor to left entorhinal cortex thickness ( = −0.419,
 = 0.003) and from left entorhinal cortex thickness to BVMT-R Total
ecall score ( = 0.403, p = 0.008) were statistically signiﬁcant.
The second target model speciﬁed indirect relations from MetS
isk factor to BVMT-R Delayed Recall score via left entorhinal cortex
hickness as a mediating variable in middle-aged adults. The tar-
et model ﬁt well statistically [2(1, N = 34) = 0.077, p = 0.781], and
escriptively (CFI = 1.000, RMSEA < 0.001, and SRMR = 0.015). The
ffect from MetS risk factor to left entorhinal cortex thickness was
tatistically signiﬁcant ( = −0.382, p = 0.028). The effect from left
ntorhinal cortex thickness to BVMT-R Delayed Recall score was
ot statistically signiﬁcant ( = 0.204, p = 0.161).
.3. Exploratory analyses
.3.1. Exploratory analyses of hypertension and brain structure
Relationships between blood pressure (systolic and diastolic
easurements) and brain structure were analyzed using regression
nalyses, covarying for age, gender, and T1 type. Systolic blood pres-
ure was signiﬁcantly associated with right MTL  cortical thickness
n middle-aged adults (t = −2.198, p = 0.036). However, when sys-
olic blood pressure was added as covariate to the ANCOVA model
nalyzing between-group differences in right MTL  cortical thick-
ess, systolic blood pressure was no longer signiﬁcant (p = 0.350)
nd the effect of MetS group was attenuated such that it was  no
onger signiﬁcant (p = 0.101). In older adults, blood pressure mea-
ures were not associated with any structural measurements..3.2. Exploratory analyses of medication and brain structure
In middle-age adults, cortical thickness differences in the left
ntorhinal cortex (p = 0.047) remained statistically signiﬁcant afterLetters 636 (2017) 225–232
adding any medication use to the model. When assessing the effect
of extensive medication use, group differences persisted in the
left MTL  (p = 0.044), and the left entorhinal cortex (p = 0.018) in
middle-aged adults. There continued to be no signiﬁcant struc-
tural differences in older adults after adjusting for medication use
in either model.
4. Discussion
Hypothesis 1. Structural Differences in MetS
This study examined structural brain differences in middle-aged
and older adults with MetS. Between-group analyses revealed that
middle-aged adults with MetS had signiﬁcantly smaller overall
cortical thickness in the MTL, including the entorhinal cortex. In
contrast, in the older adults, although there were trends toward a
lower hippocampal volume, the MetS and control groups showed
no signiﬁcant differences in MTL  thickness.
Middle age is increasingly being identiﬁed as a pivotal develop-
mental period. Research suggests that lifestyle factors, especially
during midlife, are associated with increased risk of dementia and
AD [5]. The ﬁndings suggest that MetS differentially affects brain
structure in middle age and older adulthood. It is not known why
older adults with MetS did not show reduced cortical thickness
compared to controls, as was  seen in middle-age. Obesity and
related MetS conditions rise with age with peak levels of MetS in
the 6th decade for men and in the 7th decade for women and are
associated with increased mortality [17], thus we  speculate that
a survivor effect may  be present. Older adults with more chronic
or severe MetS may  have shorter life spans, be screened out for
dementia or be unlikely to volunteer; e.g., due to cardiovascular
disease. The data suggest the importance of longitudinal data that
will further elucidate the association between metabolic syndrome,
cortical thickness in MTL  areas and memory measures through mid-
dle age and older adulthood. In addition, it will be important to
measure the duration of the components of metabolic syndrome.
Given that the earliest neuropathological changes in AD occur in
entorhinal cortex, these data may  be of use in understanding the
inﬂuence of MetS on the development of cognitive decline and
dementia.
We might speculate that middle-aged adults with MetS may
demonstrate accelerated cerebral atrophy in MTL  areas, which in
turn may  put this population at increased risk for cognitive decline
and dementia. Though entorhinal atrophy is associated with typi-
cal aging and entorhinal atrophy in typically aging adults has been
found to be predictive of memory performance [18], it is also an
important feature of Alzheimer’s disease. MRI  studies in mild AD
and AD populations have consistently reported volume loss in the
entorhinal cortex [19], and longitudinal MRI  studies of AD have
found increased rates of atrophy in the entorhinal cortex relative
to other brain structures [20]. In light of these ﬁndings, the results
of the present study suggest that adults with metabolic syndrome
may  be susceptible to increased atrophy in brain regions that are
consistently implicated early in neurodegenerative disease.
Hypothesis 2. Relationships between brain structure and number
of MetS risk factors
Past research has shown several individual criteria of the MetS
are associated with reduced cortical thickness or volumes. How-
ever, less is known about how number of individual vascular and
metabolic risk factors, or cumulative MetS risk factors, affect brain
structure. Yaffe (2007) showed that a composite measure of MetS
is associated with greater risk for cognitive decline than any indi-
vidual risk factor alone, except possibly insulin resistance [21]. In
the present study, associations between cortical thickness in MTL
regions and number of MetS risk factors were demonstrated in
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iddle-aged adults. Cortical thickness of the control region was
ot associated with number of MetS risk factors, which suggests
hat effects of MetS on brain structure in the middle-aged are not
ndiscriminate, but rather are regionally speciﬁc.
In contrast to middle-aged adults, there were no signiﬁcant
elationships between MTL  measures and risk factor burden in
lder adults. Recently, Tchistiakova et al. showed that older adults
ith both hypertension and T2DM had signiﬁcantly less cortical
hickness in the occipital lobe compared to older adults with hyper-
ension alone [22]. Thus, there is some evidence that older adults
ith multiple risk factors have less cortical thickness than adults
ith one risk factor, but not in the MTL. Future studies should build
pon this line of inquiry to evaluate the contribution of cumulative
ascular and metabolic risk factors to brain structure.
ypothesis 3. Relationships between MTL  structure and memory
A number of studies have suggested that MetS has a negative
mpact on memory processes [2]. Poor performance on the BVMT-
 indicates difﬁculty in encoding and recalling new memories. In
iddle-aged adults, there were no signiﬁcant associations between
rain structure and memory. In older adults, hippocampal volumes
ere signiﬁcantly correlated with both BVMT-R Total Recall and
elayed Recall. Overall, these ﬁndings suggest the hypothesis that
he relationships between measures of memory function and MTL
tructure may  progress over time in MetS. We  might speculate that
hese differences in middle-aged and older adults reﬂect the same
attern as the development of pathology in AD which progresses
rom the transentorhinal/entorhinal area to hippocampus.
ypothesis 4. Mediation Analyses
The present study was not designed to investigate the contri-
ution of individual MetS criteria to differences in memory, but
ather focused on the role of structural changes in mediating the
elationship between MetS and memory in middle-aged adults.
n middle-aged adults, left entorhinal cortical thickness mediated
he relationship between metabolic risk factor burden and BVMT-
 Total Recall. The results of the path analysis suggest that the
elationship between cumulative MetS symptoms and episodic
emory function is in part due to structural changes in the entorhi-
al cortex. It has repeatedly been shown that MetS is associated
ith poorer cognitive performance relative to healthy controls, but
his is one of the ﬁrst studies to show that poorer memory in MetS is
elated to an important structure implicated in neurodegenerative
isease, the entorhinal cortex.
.1. Exploratory analyses: hypertension and brain structure
Hypertension is a known risk factor for cognitive impairment
nd dementia [3], thus, we also explored the relationships between
lood pressure and MTL  cortical thickness and hippocampal vol-
me. Systolic and diastolic blood pressure were not signiﬁcantly
ssociated with structure of MTL  memory regions, with the excep-
ion that systolic blood pressure was associated with right MTL
ortical thickness in middle age. While hypertension has been
hown to increase risk for cognitive impairment and dementia,
hese results suggest that hypertension alone cannot account for
he differences seen in MTL  structure. Further research is needed
o fully investigate the potential inﬂuence of altered blood pressure
n the integrity of temporal pathways. Recently, it has been shown
hat markers of arterial stiffness such as pulse-wave velocity, cen-
ral blood pressure, and central pulse pressure were associated with
TL  atrophy in older adults with memory complaints [23].Letters 636 (2017) 225–232 231
4.2. Exploratory analyses: medication and cortical thickness
When we added use of any medication to the existing mod-
els, differences in cortical thickness remained between MetS and
controls in the left entorhinal cortex. Further, adding extensive
medication use to the model did not alter the signiﬁcant group
differences in the left entorhinal cortex and the left MTL. Thus,
accounting for medication use did not signiﬁcantly alter the major
ﬁndings related to cortical thickness in this study. In future studies,
it would be of interest to include duration of medication use.
4.3. Strengths & limitations
An important strength of this study is the use of cortical thick-
ness as a measure of brain integrity. Cortical thickness has been
shown to be regionally speciﬁc [12], and changes in cortical thick-
ness are present in neurodegenerative diseases such as AD [24].
As with any study, the present study had limitations. The present
study is cross-sectional. Nevertheless, it suggests relationships
among risk factor burden, measures of MTL  thickness and memory
performance in middle-aged and older adults. The present results
in a cross-sectional sample suggest the need for future studies to
follow individuals with MetS longitudinally to further understand
the degree to which structural changes in MTL  mediate memory
impairment and incipient dementia in MetS.
5. Conclusions
The present study is the ﬁrst to demonstrate that not only do
middle-aged adults with metabolic syndrome have smaller mea-
sures of cortical thickness compared to metabolically healthy adults
in medial temporal regions, including the entorhinal cortex, but
that these measures mediate the association between metabolic
disease burden and performance on episodic memory function. The
current study also suggests that MetS may  differentially affect brain
structure in middle age and older adulthood. Older adults with
MetS did not show signiﬁcantly decreased medial temporal cortical
thickness, though there was a trend (p < 0.046) toward smaller hip-
pocampal volumes relative to older controls. Given the established
connections between medial temporal lobe atrophy and cognitive
decline and dementia, our ﬁndings support the importance of lon-
gitudinal investigation of middle-aged and older adults with MetS
who may  be at increased risk for cognitive decline and pathological
aging.
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